Candriam S.C.A. Myriad Genetics Inc Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$14.51 - $20.99 $18,006 - $26,048	1,241 Added 2.81%	45,398 $658,000
Q3 2022 Nov 10, 2022	BUY	$18.21 - $27.88 $804,098 - $1.23 Million	44,157 New	44,157 $843,000
Q2 2019 Aug 01, 2019	SELL	$22.67 - $35.0 $2.99 Million - $4.61 Million	-131,732 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$26.93 - $34.7 $3.55 Million - $4.57 Million	131,732 New	131,732 $4.37 Million

253

90.5M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.11B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.